Histopathological evaluation revealed an oligodendroglioma, IDH1 mutated, 1p/19q-co-deleted WHO II, and a concomitant and adjuvant radiochemotherapy (50 Gy) with temozolomide (6 cycles) was initiated [11]. The gene discussed is IDH1; the disease is oligodendroglioma.